Thermo Fisher set to benefit from demand for testing kits, vaccines
Go back to Thermo Fisher set to benefit from demand for testing kits, vaccines| Thermo Fisher Scientific (NYSE: TMO) | Delayed: 658.08 -0.68 (0.1%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $658.76 | 52 Week High | $160.68 | |||
| Open | $656.41 | 52 Week Low | $119.75 | |||
| Day High | $659.21 | P/E | 188.02 | |||
| Day Low | $651.54 | EPS | $3.50 | |||
| Volume | 437,714 | |||||
